Journals / Türk Kardiyoloji Derneği Arşivi / 2010 / Cilt: 38 - Sayı: 8

INR’si 4.4 olan bir hastada çok geç dönem ilaç salınımlı stent trombozu

Very late drug-eluting stent thrombosis in a patient with an INR of 4.4

Pages
561–563
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

He was successfully revascularized without any complication and was discharged free of symptoms.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Duration of dual antiplatelet therapy after drug-eluting stent implantation is still an important issue awaiting a definite answer.
📊
Key Findings & Data:A 50-year-old male patient was admitted with acute-onset chest pain and was diagnosed to have acute anterior myocardial infarction due to very late stent thrombosis.
💡
Conclusion & Impact:He was successfully revascularized without any complication and was discharged free of symptoms.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Duration of dual antiplatelet therapy after drug-eluting stent implantation is still an important issue awaiting a definite answer. A 50-year-old male patient was admitted with acute-onset chest pain and was diagnosed to have acute anterior myocardial infarction due to very late stent thrombosis. He had a 38-month history of two sirolimus-eluting stent implantation in the proximal left anterior descending (LAD) coronary artery. He had been on warfarin along with clopidogrel 75 mg/day until he decided to cease clopidogrel before a minor dental procedure 10 days before. Findings of physical examination and laboratory tests were normal except for an INR value of 4.4. After a loading dose of 300 mg clopidogrel, he was immediately taken to the catheterization laboratory. Angiography of the left system showed total occlusion of the proximal LAD with a thrombus at the level of the proximal stent. He was successfully revascularized without any complication and was discharged free of symptoms.

Özet

İlaç salınımlı stent yerleştirme sonrası ikili antitrombosit tedavinin ne kadar sürdürüleceği hala kesin yanıt bekleyen önemli bir konudur. Elli yaşında erkek hasta ani başlangıçlı göğüs ağrısıyla yatırıldı ve çok geç dönem stent trombozuna bağlı akut anteriyor miyokart enfarktüsü tanısı kondu. Hastaya 38 ay önce sol ön inen koroner arter proksimaline iki adet sirolimus salınımlı stent yerleştirilmişti. Düzenli olarak warfarin ile birlikte 75 mgr/gün klopidogrel tedavisi gören hasta, 10 gün önce basit bir diş tedavisi nedeniyle klopidogrel kullanmayı bırakmıştı. Fizik muayene bulguları ve laboratuvar testleri, INR değerinin 4.4 olması dışında normaldi. Hastaya 300 mgr klopidogrel yükleme dozu verildi ve acil olarak kateter laboratuvarına alındı. Sol sistem anjiyografisinde, proksimal stent bölgesinde sol ön inen arter proksimalinde tam tıkanıklık görüldü. Başarılı revaskülarizasyon işlemi sonrasında hasta semptomsuz olarak taburcu edildi.

🔖

Cite This Article

KUMBASAR, D., CANDEMİR, B., ÖZDEMİR, A. O., GÜLEÇ, S. (2022). INR’si 4.4 olan bir hastada çok geç dönem ilaç salınımlı stent trombozu. Türk Kardiyoloji Derneği Arşivi, Cilt: 38 - Sayı: 8, 561–563. https://ajindex.com/articles/633265

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31
  2. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005;45:2088-92
  3. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug eluting versus bare-metal stents. J Am Coll Cardiol 2006;48:2584-91
  4. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30
  5. Mauri L, Hsieh WH, Massaro JM, Ho KK, D’Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007; 356:1020-9
  6. Nordmann AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J 2006;27:2784-814
  7. Serruys PW, Strauss BH, Beatt KJ, Bertrand ME, Puel J, Rickards AF, et al. Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med 1991;324:13-7
  8. Schatz RA, Baim DS, Leon M, Ellis SG, Goldberg S, Hirshfeld JW, et al. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation 1991;83:148-61
  9. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994;331:496-501
  10. Karjalainen PP, Vikman S, Niemelä M, Porela P, Ylitalo A, Vaittinen MA, et al. Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment. Eur Heart J 2008;29:1001-10.